|4Jul 18, 4:37 PM ET

Derby Michael 4

4 · Acasti Pharma Inc. · Filed Jul 18, 2023

Insider Transaction Report

Form 4
Period: 2023-07-14
Transactions
  • Award

    Stock Options (Right to Buy)

    2023-07-14+12,50012,500 total
    Exercise: $2.64Exp: 2033-07-14Class A Common Shares (12,500 underlying)
Footnotes (1)
  • [F1]Stock options granted on 07/14/2023 under the Acasti Pharma Stock Option Plan, which vest and become exercisable in equal monthly installments over a period of 12 months.

Documents

2 files
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

  • EX-24

    POWER OF ATTORNEY